Clinical trial
A Clinical Study to Evaluate Ospemifene in the Treatment of Vulvar and Vaginal…
NCT00276094 · Shionogi, Industry · Completed
Key facts
| NCT number | NCT00276094 |
|---|---|
| Title | A Clinical Study to Evaluate Ospemifene in the Treatment of Vulvar and Vaginal Atrophy in Postmenopausal Women |
| Official title | Efficacy and Safety of Ospemifene in the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women: A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing Oral Ospemifene 30 and 60 Mg Daily Doses With Placebo |
| Lead sponsor | Shionogi, Industry |
| Collaborators | Hormos Medical Industry QuatRx Pharmaceuticals |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Atrophy, Vaginal Diseases |
| Intervention type | Drug |
| Interventions | Ospemifene 30 mg, Ospemifene 60 mg, Placebo, Nonhormonal vaginal lubricant |
| Enrollment | 826 |
| Start date | Jan 1, 2006 |
| Completion | Dec 1, 2007 |
| First posted | Jan 12, 2006 |
| Last update posted | Jun 28, 2013 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: